Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Randomized Controlled Trial
100%
Cardiovascular Prevention
100%
Coronary Artery Calcium
100%
Primary Prevention
66%
Statins
50%
Add-on Therapy
33%
Risk Estimation
33%
Coronary Artery Calcium Score
33%
Novel Therapies
33%
Relative Risk Reduction
33%
Ankle-brachial Index
16%
Multi-Ethnic Study of Atherosclerosis
16%
C-reactive Protein
16%
High-risk Individuals
16%
Entry Criteria
16%
Incident Event
16%
Absolute Risk
16%
High-sensitivity C-reactive Protein (hs-CRP)
16%
Second Best
16%
Atherosclerotic Cardiovascular Disease Risk
16%
High-intensity Statin Therapy
16%
Participant Selection
16%
10-year Atherosclerotic Cardiovascular Disease Risk
16%
Statin-naïve
16%
Trial Costs
16%
Nursing and Health Professions
Sample Size
100%
Primary Prevention
100%
Cardiovascular System
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
75%
Coronary Artery Atherosclerosis
75%
Add on Therapy
50%
Coronary Artery Calcium Score
50%
Efficacy
50%
Statin (Protein)
25%
C Reactive Protein
25%
Atherosclerosis
25%
Ankle Brachial Index
25%
Statins therapy
25%
Medicine and Dentistry
Randomized Controlled Trial
100%
Cardiovascular System
100%
Coronary Artery Calcium
100%
Health Care Cost
62%
Statin
62%
Primary Prevention
50%
Arteriosclerotic Heart Disease
37%
Add on Therapy
25%
Risk Evaluation
25%
Relative Risk Reduction
25%
Atherosclerosis
12%
Ankle Brachial Index
12%
C Reactive Protein
12%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Coronary Artery Atherosclerosis
50%
Statin (Protein)
33%
Add on Therapy
33%
Risk Evaluation
33%
Atherosclerosis
16%
C Reactive Protein
16%
Neuroscience
Randomized Controlled Trial
100%
Cardiovascular System
100%
Statin
83%
C-Reactive Protein
16%